147 related articles for article (PubMed ID: 9414658)
1. Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension.
Okayasu I; Osakabe T; Fujiwara M; Fukuda H; Kato M; Oshimura M
Jpn J Cancer Res; 1997 Oct; 88(10):965-70. PubMed ID: 9414658
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in benign and malignant thyroid tumors.
Haugen BR; Nawaz S; Markham N; Hashizumi T; Shroyer AL; Werness B; Shroyer KR
Thyroid; 1997 Jun; 7(3):337-42. PubMed ID: 9226200
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity and telomere length in benign and malignant human thyroid tissues.
Kammori M; Takubo K; Nakamura K; Furugouri E; Endo H; Kanauchi H; Mimura Y; Kaminishi M
Cancer Lett; 2000 Oct; 159(2):175-81. PubMed ID: 10996729
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Brousset P; Chaouche N; Leprat F; Branet-Brousset F; Trouette H; Zenou RC; Merlio JP; Delsol G
J Clin Endocrinol Metab; 1997 Dec; 82(12):4214-6. PubMed ID: 9398742
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in thyroid malignancy.
Lo CY; Lam KY; Chan KT; Luk JM
Thyroid; 1999 Dec; 9(12):1215-20. PubMed ID: 10646661
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity in benign and malignant human thyroid tissues.
Cheng AJ; Lin JD; Chang T; Wang TC
Br J Cancer; 1998 Jun; 77(12):2177-80. PubMed ID: 9649130
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease.
Bornstein-Quevedo L; García-Hernández ML; Camacho-Arroyo I; Herrera MF; Angeles AA; Treviño OG; Gamboa-Domínguez A
Endocr Pathol; 2003; 14(3):213-19. PubMed ID: 14586066
[TBL] [Abstract][Full Text] [Related]
8. Function of HSP90 and p23 in the telomerase complex of thyroid tumors.
Boltze C; Schneider-Stock R; Roessner A; Quednow C; Hoang-Vu C
Pathol Res Pract; 2003; 199(9):573-9. PubMed ID: 14621192
[TBL] [Abstract][Full Text] [Related]
9. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
10. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas.
Okayasu I; Mitomi H; Yamashita K; Mikami T; Fujiwara M; Kato M; Oshimura M
J Cancer Res Clin Oncol; 1998; 124(8):444-9. PubMed ID: 9750021
[TBL] [Abstract][Full Text] [Related]
12. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
13. TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors.
Matsuse M; Yabuta T; Saenko V; Hirokawa M; Nishihara E; Suzuki K; Yamashita S; Miyauchi A; Mitsutake N
Sci Rep; 2017 Feb; 7():41752. PubMed ID: 28150740
[TBL] [Abstract][Full Text] [Related]
14. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid.
Soares P; Cameselle-Teijeiro J; Sobrinho-Simões M
Histopathology; 1994 Mar; 24(3):205-10. PubMed ID: 8200621
[TBL] [Abstract][Full Text] [Related]
16. Protein expression of double-stranded RNA-activated protein kinase in thyroid carcinomas: correlations with histologic types, pathologic parameters, and Ki-67 labeling.
Terada T; Maeta H; Endo K; Ohta T
Hum Pathol; 2000 Jul; 31(7):817-21. PubMed ID: 10923918
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
Kammori M; Nakamura K; Hashimoto M; Ogawa T; Kaminishi M; Takubo K
Int J Oncol; 2003 May; 22(5):985-91. PubMed ID: 12684663
[TBL] [Abstract][Full Text] [Related]
18. Mixed columnar cell and tall cell variant of papillary carcinoma of thyroid: a case report and review of the literature.
Putti TC; Bhuiya TA
Pathology; 2000 Nov; 32(4):286-9. PubMed ID: 11186427
[TBL] [Abstract][Full Text] [Related]
19. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
[TBL] [Abstract][Full Text] [Related]
20. Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.
Straight AM; Patel A; Fenton C; Dinauer C; Tuttle RM; Francis GL
J Endocrinol Invest; 2002 Apr; 25(4):302-8. PubMed ID: 12030599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
